Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDSCongenital, Hereditary, and Neonatal Diseases and Abnormalities, GATA2 deficiency with susceptibility to MDS/AML, Hemic and Lymphatic Diseases, Myelodysplastic Syndrome Acute Myeloid Leukemia, Neoplasms by Histologic Type, acute myeloid leukemia, anemia, bone marrow disorder, hematologic disorder, hereditary disease, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasmRecruitingPhase 12026-06-01NCT06372717

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Apollo Therapeutics Ltd4

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom4
Hollywood Private HospitalNedlandsAustralia11
Monash HealthClaytonAustralia74
Royal Perth HospitalPerthAustralia43
Sarah Cannon Research Institute UKLondonUnited Kingdom1
St. Vincent's Hospital MelbourneFitzroyAustralia12
The Alfred HospitalMelbourneAustralia110
The Royal Marsden HospitalLondonUnited Kingdom2
University Hospital of WalesCardiffUnited Kingdom31